Optimizing Care Across the Continuum for Older Adults with Lung Cancer: A Review

Overview

Journal Cancers (Basel)

Publisher MDPI

Specialty Oncology

Date 2024 Nov 27

PMID 39594755

Authors

Leah Thompson

Caterina Florissi

Jaewon Yoon

Anupama Singh

Anurag Saraf

Affiliations

Soon will be listed here.

Abstract

Older adults with lung cancer experience inferior clinical outcomes compared to their younger counterparts. This review provides the scaffolding to address these disparities by delineating (1) the distinct and varied care needs of older adults with lung malignancies, (2) evidence-based measures for identifying subgroups within this population meriting tailored approaches to care, (3) age-specific considerations for the selection of cancer-directed therapy, and (4) opportunities for future work to enhance clinical outcomes and care delivery.

References

Loh K, Mohile S, Lund J, Epstein R, Lei L, Culakova E . Beliefs About Advanced Cancer Curability in Older Patients, Their Caregivers, and Oncologists. Oncologist. 2019; 24(6):e292-e302. PMC: 6656513. DOI: 10.1634/theoncologist.2018-0890. View

Firat S, Byhardt R, Gore E . Comorbidity and Karnofksy performance score are independent prognostic factors in stage III non-small-cell lung cancer: an institutional analysis of patients treated on four RTOG studies. Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys. 2002; 54(2):357-64. DOI: 10.1016/s0360-3016(02)02939-5. View

Turner J, Shakib S, Singhal N, Hogan-Doran J, Prowse R, Johns S . Prevalence and factors associated with polypharmacy in older people with cancer. Support Care Cancer. 2014; 22(7):1727-34. DOI: 10.1007/s00520-014-2171-x. View

Nipp R, Greer J, El-Jawahri A, Moran S, Traeger L, Jacobs J . Coping and Prognostic Awareness in Patients With Advanced Cancer. J Clin Oncol. 2017; 35(22):2551-2557. PMC: 5536163. DOI: 10.1200/JCO.2016.71.3404. View

Mohamed M, Mohile S, Juba K, Awad H, Wells M, Loh K . Association of polypharmacy and potential drug-drug interactions with adverse treatment outcomes in older adults with advanced cancer. Cancer. 2023; 129(7):1096-1104. PMC: 10958985. DOI: 10.1002/cncr.34642. View

Puts M, Hardt J, Monette J, Girre V, Springall E, Alibhai S . Use of geriatric assessment for older adults in the oncology setting: a systematic review. J Natl Cancer Inst. 2012; 104(15):1133-63. PMC: 3413614. DOI: 10.1093/jnci/djs285. View

Cohen M, Althouse A, Arnold R, White D, Chu E, Rosenzweig M . Primary Palliative Care Improves Uptake of Advance Care Planning Among Patients With Advanced Cancers. J Natl Compr Canc Netw. 2023; 21(4):383-390. PMC: 10477933. DOI: 10.6004/jnccn.2023.7002. View

Asmis T, Ding K, Seymour L, Shepherd F, Leighl N, Winton T . Age and comorbidity as independent prognostic factors in the treatment of non small-cell lung cancer: a review of National Cancer Institute of Canada Clinical Trials Group trials. J Clin Oncol. 2008; 26(1):54-9. DOI: 10.1200/JCO.2007.12.8322. View

Fried T, Tinetti M, Iannone L, OLeary J, Towle V, Van Ness P . Health outcome prioritization as a tool for decision making among older persons with multiple chronic conditions. Arch Intern Med. 2011; 171(20):1854-6. PMC: 4036681. DOI: 10.1001/archinternmed.2011.424. View

10.

Volandes A, Zupanc S, Lakin J, Cabral H, Burns E, Carney M . Video Intervention and Goals-of-Care Documentation in Hospitalized Older Adults: The VIDEO-PCE Randomized Clinical Trial. JAMA Netw Open. 2023; 6(9):e2332556. PMC: 10495866. DOI: 10.1001/jamanetworkopen.2023.32556. View

11.

Kirkhus L, Saltyte Benth J, Gronberg B, Hjermstad M, Rostoft S, Harneshaug M . Frailty identified by geriatric assessment is associated with poor functioning, high symptom burden and increased risk of physical decline in older cancer patients: Prospective observational study. Palliat Med. 2019; 33(3):312-322. PMC: 6376598. DOI: 10.1177/0269216319825972. View

12.

Islam K, Jiang X, Anggondowati T, Lin G, Ganti A . Comorbidity and Survival in Lung Cancer Patients. Cancer Epidemiol Biomarkers Prev. 2015; 24(7):1079-85. DOI: 10.1158/1055-9965.EPI-15-0036. View

13.

Bellera C, Rainfray M, Mathoulin-Pelissier S, Mertens C, Delva F, Fonck M . Screening older cancer patients: first evaluation of the G-8 geriatric screening tool. Ann Oncol. 2012; 23(8):2166-2172. DOI: 10.1093/annonc/mdr587. View

14.

Boen C, Barrow D, Bensen J, Farnan L, Gerstel A, Hendrix L . Social Relationships, Inflammation, and Cancer Survival. Cancer Epidemiol Biomarkers Prev. 2018; 27(5):541-549. PMC: 5932225. DOI: 10.1158/1055-9965.EPI-17-0836. View

15.

Rawle M, Richards M, Davis D, Kuh D . The prevalence and determinants of polypharmacy at age 69: a British birth cohort study. BMC Geriatr. 2018; 18(1):118. PMC: 5956732. DOI: 10.1186/s12877-018-0795-2. View

16.

Kim M, Kim S, Lee M, Eom J . Recent Advances in Adjuvant Therapy for Non-Small-Cell Lung Cancer. Tuberc Respir Dis (Seoul). 2023; 87(1):31-39. PMC: 10758313. DOI: 10.4046/trd.2023.0085. View

17.

Higginson I, Gao W, Jackson D, Murray J, Harding R . Short-form Zarit Caregiver Burden Interviews were valid in advanced conditions. J Clin Epidemiol. 2009; 63(5):535-42. DOI: 10.1016/j.jclinepi.2009.06.014. View

18.

Pang H, Wang X, Stinchcombe T, Wong M, Cheng P, Ganti A . Enrollment Trends and Disparity Among Patients With Lung Cancer in National Clinical Trials, 1990 to 2012. J Clin Oncol. 2016; 34(33):3992-3999. PMC: 5477832. DOI: 10.1200/JCO.2016.67.7088. View

19.

Mohile S, Fan L, Reeve E, Jean-Pierre P, Mustian K, Peppone L . Association of cancer with geriatric syndromes in older Medicare beneficiaries. J Clin Oncol. 2011; 29(11):1458-64. PMC: 3082984. DOI: 10.1200/JCO.2010.31.6695. View

20.

Tang M, Pearson S, Schaffer A, Lewis C, John T, Simes R . Are clinical trial eligibility criteria representative of older patients with lung cancer? A population-based data linkage study. J Geriatr Oncol. 2021; 12(6):930-936. DOI: 10.1016/j.jgo.2021.02.003. View